Jingshang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jingshang Wang has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Ye Huang
Emergency Department, Xiyuan Hospital, China Academy of Chinese Medical Science, Beijing, China
3 shared publications Huijun Yin
2 shared publicationsJiacheng Zhang
Department of Traditional Chinese Medicine, Peking University Third Hospital
2 shared publicationsKeji Chen
2 shared publications- Siqi Guan
TCM Department, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100026, China
2 shared publications - Yang Ye
State Key Laboratory of Female Fertility Promotion, Department of Traditional Chinese Medicine, Peking University Third Hospital, Beijing 100191, China
2 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1945675
Supramolecular soft matter in traditional Chinese medicine: multiscale structure–function evidence, critical limitations, and translational challenges
Plant metabolites used in traditional Chinese medicine (TCM) can form supramolecular assemblies in decoctions or in formulations prepared from purified molecules. These experimental settings support different conclusions. This narrative review examines TCM-derived supramolecular soft matter (TCM-derived SSM) through relationships among molecular interactions, assembly structure, physicochemical properties, and biological responses. It distinguishes assemblies isolated from decoctions, recombined extracts, formulations prepared from purified metabolites, and mixtures of defined metabolites with extracts. Micelles, vesicles, nanoparticles (NPs), nanofibers (NFs), and supramolecular gels provide examples, while carbonized products and covalently crosslinked carriers are discussed as related materials with distinct formation mechanisms. Selected studies associate morphology, surface chemistry, or deformability with altered delivery and preclinical activity. However, the presence of particles, successful reconstitution, and improved efficacy do not individually establish that an assembly is necessary for the effect of a complete preparation. Our contribution is an evidence-oriented comparison of preparation routes, structural measurements, biological comparisons, and the limits of inference across these preparations. We also examine artificial intelligence (AI)-assisted modeling and candidate critical quality attributes (CQAs) within a Quality by Design (QbD) perspective. Predictive design and assembly-based quality control are presented as research prospects that require reproducible measurements, appropriate controls, and validation across batches and biological settings. Self-assembly is a general physicochemical phenomenon; TCM provides a context for studying defined botanical drug combinations and preparation processes rather than evidence of properties unique to one medical tradition. We position this physical-state perspective within the established literature on synergy, antagonism and pharmacokinetic interactions in botanical mixtures.
- 21 October 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1945675
Open AccessSupramolecular soft matter in traditional Chinese medicine: multiscale structure–function evidence, critical limitations, and translational challenges
Plant metabolites used in traditional Chinese medicine (TCM) can form supramolecular assemblies in decoctions or in formulations prepared from purified molecules. These experimental settings support different conclusions. This narrative review examines TCM-derived supramolecular soft matter (TCM-derived SSM) through relationships among molecular interactions, assembly structure, physicochemical properties, and biological responses. It distinguishes assemblies isolated from decoctions, recombined extracts, formulations prepared from purified metabolites, and mixtures of defined metabolites with extracts. Micelles, vesicles, nanoparticles (NPs), nanofibers (NFs), and supramolecular gels provide examples, while carbonized products and covalently crosslinked carriers are discussed as related materials with distinct formation mechanisms. Selected studies associate morphology, surface chemistry, or deformability with altered delivery and preclinical activity. However, the presence of particles, successful reconstitution, and improved efficacy do not individually establish that an assembly is necessary for the effect of a complete preparation. Our contribution is an evidence-oriented comparison of preparation routes, structural measurements, biological comparisons, and the limits of inference across these preparations. We also examine artificial intelligence (AI)-assisted modeling and candidate critical quality attributes (CQAs) within a Quality by Design (QbD) perspective. Predictive design and assembly-based quality control are presented as research prospects that require reproducible measurements, appropriate controls, and validation across batches and biological settings. Self-assembly is a general physicochemical phenomenon; TCM provides a context for studying defined botanical drug combinations and preparation processes rather than evidence of properties unique to one medical tradition. We position this physical-state perspective within the established literature on synergy, antagonism and pharmacokinetic interactions in botanical mixtures.
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Diabetic Erectile Dysfunction: Erectile Reserve and Treatment-Response Heterogeneity
Huang B, et al. World J Mens Health. 2026 ;44:e90. https://doi.org/10.5534/wjmh.260230
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Open AccessDiabetic Erectile Dysfunction: Erectile Reserve and Treatment-Response Heterogeneity
Huang B, et al. World J Mens Health. 2026 ;44:e90. https://doi.org/10.5534/wjmh.260230
- Open Access
- 14 July 2022
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 54 (07) , 419-428
Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability
The development and progression of the complications of chronic diabetes mellitus are attributed not only to increased blood glucose levels but also to glycemic variability. Therefore, a deeper understanding of the role of glycemic variability in the development of diabetic complications may provide more insight into targeted clinical treatment strategies in the future. Previously, the mechanisms implicated in glycemic variability-induced diabetic complications have been comprehensively discussed. However, endothelial dysfunction and platelet hyperactivation, which are two newly recognized critical pathogenic factors, have not been fully elucidated yet. In this review, we first evaluate the assessment of glycemic variability and then summarise the roles of endothelial dysfunction and platelet hyperactivation in glycemic variability-induced complications of diabetes, highlighting the molecular mechanisms involved and their interconnections.
- 14 July 2022
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 54 (07) , 419-428
Open AccessEndothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability
The development and progression of the complications of chronic diabetes mellitus are attributed not only to increased blood glucose levels but also to glycemic variability. Therefore, a deeper understanding of the role of glycemic variability in the development of diabetic complications may provide more insight into targeted clinical treatment strategies in the future. Previously, the mechanisms implicated in glycemic variability-induced diabetic complications have been comprehensively discussed. However, endothelial dysfunction and platelet hyperactivation, which are two newly recognized critical pathogenic factors, have not been fully elucidated yet. In this review, we first evaluate the assessment of glycemic variability and then summarise the roles of endothelial dysfunction and platelet hyperactivation in glycemic variability-induced complications of diabetes, highlighting the molecular mechanisms involved and their interconnections.
- Open Access
- 1 January 2021
- Published by Acta Physica Sinica, Chinese Physical Society and Institute of Physics, Chinese Academy of Sciences in Acta Physica Sinica
- Vol. 70 (3) , 034206
Recent progress of coherent combining technology in femtosecond fiber lasers
Widely employed in fundamental research, industrial processing, and biomedicine, femtosecond fiber lasers exhibit many attractive features such as high average power, good heat dissipation, excellent beam quality, and compact footprint. Coherent combining technology can effectively suppress the detrimental nonlinear and thermal effects in the fiber amplifiers, and therefore further increase the output pulse energy and average power of femtosecond fiber lasers. In this article, we mainly discuss different coherent combining techniques in high-power ultrafast Yb-fiber laser systems and the relevant phase-locking methods. We believe that the advent of new coherent combining techniques will further improve the average power and pulse energy of femtosecond fiber laser systems, thereby opening up some new research areas.
- 1 January 2021
- Published by Acta Physica Sinica, Chinese Physical Society and Institute of Physics, Chinese Academy of Sciences in Acta Physica Sinica
- Vol. 70 (3) , 034206
Open AccessRecent progress of coherent combining technology in femtosecond fiber lasers
Widely employed in fundamental research, industrial processing, and biomedicine, femtosecond fiber lasers exhibit many attractive features such as high average power, good heat dissipation, excellent beam quality, and compact footprint. Coherent combining technology can effectively suppress the detrimental nonlinear and thermal effects in the fiber amplifiers, and therefore further increase the output pulse energy and average power of femtosecond fiber lasers. In this article, we mainly discuss different coherent combining techniques in high-power ultrafast Yb-fiber laser systems and the relevant phase-locking methods. We believe that the advent of new coherent combining techniques will further improve the average power and pulse energy of femtosecond fiber laser systems, thereby opening up some new research areas.
- Open Access
- 10 April 2019
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-11
A Protective Role of Paeoniflorin in Fluctuant Hyperglycemia-Induced Vascular Endothelial Injuries through Antioxidative and Anti-Inflammatory Effects and Reduction of PKCβ1
Hyperglycemia fluctuation is associated with diabetes mellitus (DM) complications when compared to persistent hyperglycemia. Previous studies have shown that paeoniflorin (PF), through its antiapoptosis, anti-inflammation, and antithrombotic properties, effectively protects against cardiovascular and cerebrovascular disease. However, the mechanism underlying the protection from PF against vascular injuries induced by hyperglycemia fluctuations remains poorly understood. Herein, we investigated the potential protective role of PF on human umbilical vein endothelial cells (HUVECs) subjected to intermittent glucose levels in vitro and in DM rats with fluctuating hyperglycemia in vivo. A remarkable increased apoptosis associated with elevated inflammation, increased oxidative stress, and high protein level of PKCβ1 was induced in HUVECs by intermittently changing glucose for 8 days, and PF recovered those detrimental changes. LY333531, a potent PKCβ1 inhibitor, and metformin manifested similar effects. Additionally, in DM rats with fluctuating hyperglycemia, PF protected against vascular damage as what has been observed in vitro. Taken together, PF attenuates the vascular injury induced by fluctuant hyperglycemia through oxidative stress inhibition, inflammatory reaction reduction, and PKCβ1 protein level repression, suggesting its perspective clinical usage.
- 10 April 2019
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-11
Open AccessA Protective Role of Paeoniflorin in Fluctuant Hyperglycemia-Induced Vascular Endothelial Injuries through Antioxidative and Anti-Inflammatory Effects and Reduction of PKCβ1
Hyperglycemia fluctuation is associated with diabetes mellitus (DM) complications when compared to persistent hyperglycemia. Previous studies have shown that paeoniflorin (PF), through its antiapoptosis, anti-inflammation, and antithrombotic properties, effectively protects against cardiovascular and cerebrovascular disease. However, the mechanism underlying the protection from PF against vascular injuries induced by hyperglycemia fluctuations remains poorly understood. Herein, we investigated the potential protective role of PF on human umbilical vein endothelial cells (HUVECs) subjected to intermittent glucose levels in vitro and in DM rats with fluctuating hyperglycemia in vivo. A remarkable increased apoptosis associated with elevated inflammation, increased oxidative stress, and high protein level of PKCβ1 was induced in HUVECs by intermittently changing glucose for 8 days, and PF recovered those detrimental changes. LY333531, a potent PKCβ1 inhibitor, and metformin manifested similar effects. Additionally, in DM rats with fluctuating hyperglycemia, PF protected against vascular damage as what has been observed in vitro. Taken together, PF attenuates the vascular injury induced by fluctuant hyperglycemia through oxidative stress inhibition, inflammatory reaction reduction, and PKCβ1 protein level repression, suggesting its perspective clinical usage.
- Open Access
- 1 February 2019
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (7) , e14481
Effectiveness and safety of fluoxetine for premature ejaculation
Premature ejaculation (PE) is one of the most common male sexual dysfunctions, which can directly harm men's self-esteem and affect the stability of the relationship between husband and wife. To some extent, PE even affects the harmony and stability of society. So, men's health has gained more and more attention. As one of the long-acting selective serotonin reuptake inhibitors (SSRIs), fluoxetine has been proven to be effective in the treatment of PE by many trails. In this study, we aim to evaluate the effectiveness and safety of fluoxetine for PE to provide the newest evidence for clinical use. Literature research will be divided into 2 parts: electronic search and manual search. We will search PubMed, EMBASE, The Cochrane Library, the China National Knowledge Infrastructure (CNKI), China Biology Medicine disc (CBMdisc), the China Science and Technology Journal database (VIP), and the Wanfang database online. We will select the eligible studies published up to December 31, 2018. Manual searches mainly retrieve dissertations, ongoing trails, internal reports, and so on. We use intravaginal ejaculatory latency time (IELT) as the primary outcome of PE and we also care about the following indexes: PE Diagnostic Tool (PEDT); Arabic index of PE (AIPE); Index of PE (IPE). In addition, we will carefully observe the patient's adverse reactions during the medication. Two reviewers will read the articles, extract the data information, and assess the risk of bias independently. Data analysis will be used the software such as RevMan V.5.3.5; EndNote X7 and Stata 13.0. This study will provide a high-quality synthesis of current evidence of fluoxetine for PE from several aspects, including IELT, PEDT, AIPE, IPE, and adverse events. This systematic review will provide evidence to assess the effectiveness and safety of fluoxetine in the treatment of PE. PROSPERO CRD42018109722.
- 1 February 2019
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (7) , e14481
Open AccessEffectiveness and safety of fluoxetine for premature ejaculation
Premature ejaculation (PE) is one of the most common male sexual dysfunctions, which can directly harm men's self-esteem and affect the stability of the relationship between husband and wife. To some extent, PE even affects the harmony and stability of society. So, men's health has gained more and more attention. As one of the long-acting selective serotonin reuptake inhibitors (SSRIs), fluoxetine has been proven to be effective in the treatment of PE by many trails. In this study, we aim to evaluate the effectiveness and safety of fluoxetine for PE to provide the newest evidence for clinical use. Literature research will be divided into 2 parts: electronic search and manual search. We will search PubMed, EMBASE, The Cochrane Library, the China National Knowledge Infrastructure (CNKI), China Biology Medicine disc (CBMdisc), the China Science and Technology Journal database (VIP), and the Wanfang database online. We will select the eligible studies published up to December 31, 2018. Manual searches mainly retrieve dissertations, ongoing trails, internal reports, and so on. We use intravaginal ejaculatory latency time (IELT) as the primary outcome of PE and we also care about the following indexes: PE Diagnostic Tool (PEDT); Arabic index of PE (AIPE); Index of PE (IPE). In addition, we will carefully observe the patient's adverse reactions during the medication. Two reviewers will read the articles, extract the data information, and assess the risk of bias independently. Data analysis will be used the software such as RevMan V.5.3.5; EndNote X7 and Stata 13.0. This study will provide a high-quality synthesis of current evidence of fluoxetine for PE from several aspects, including IELT, PEDT, AIPE, IPE, and adverse events. This systematic review will provide evidence to assess the effectiveness and safety of fluoxetine in the treatment of PE. PROSPERO CRD42018109722.
- Open Access
Aberrant expression of Fcγ RIIIA contributes to development of atherosclerosis
Purpose: Previous studies have shown that Fc receptor III A of immunoglobulin G (FcγRIIIA, also named CD16) was involved in the development of coronary heart disease (CHD). However, the mechanism of CD16 in contribution to CHD development remains largely unclear. Here, we focused on the signaling pathway it stimulates in the initiation and progression of CHD. Methods: We investigated FcγRIIIA mRNA expression in the leukocytes, serum protein level of soluble CD16 (sCD16) and membrane CD16 on monocytes in 100 diagnosed CHD patients and 40 healthy people at similar ages. We determined soluble CD14 (sCD14) to analyse whether monocytes are activated or not. Macrophage colony stimulating factor (M-CSF), TNFα and IL-1 in sera were determined as well. Furthermore, the role of FcγRIIIA in the initiation and progression of CHD was analysed by monocytes adherence to human umbilical vein endothelial cells (HUVECs) in vitro and aortic atherosclerotic formation in ApoE-/-mouse model in vivo. Results: There was a significant increase of Fcγ RIIIA at the mRNA level in leukocytes (1.372±0.454), the protein level of both serum sCD16 (3.237±0.988) and membrane CD16 on monocytes (4.8±2.2%) in CHD patients when compared to the healthy control. High level of sCD14 in sera (3.744±0.896 μg/ml) was found in CHD patients. Similar to sCD14, the levels of M-CSF (120.144±32.123 pg/ml), TNFα (48.297±11.545 pg/ml) and IL-1 (75.842±20.682 pg/ml) in sera were also higher in CHD patients. Further experiments showed that the elevated level of FcγRIIIA on monocytes dramatically correlated with the adhesive efficiency of HUVECs (10.5±5.5%) in vitro, and also aortic atherosclerotic formation in ApoE-/- mouse model, along with increased levels of TNFα (41.758±9.776 pg/ml), IL-1 (71.752±13.201 pg/ml;) and soluble E-selectin (sE-selectin) (2.977±0.560 μg/ml) in sera and both the mRNA level (3.968±0.284) and the protein level (0.455±0.018) of MMP-9 in aorta. Additionally, similar to Simvastatin, IVIG pretreatment inhibited this response in ApoE-/- mice. Conclusion: Taken together, these results demonstrate that FcγRIIIA plays a crucial role in the development of athersoclerotic formation by targeting inflammatory cytokines and MMPs, and inhibition of FcγRIIIA or its signaling may represent a promising approach for the prevention and treatment of CHD.
Open AccessAberrant expression of Fcγ RIIIA contributes to development of atherosclerosis
Purpose: Previous studies have shown that Fc receptor III A of immunoglobulin G (FcγRIIIA, also named CD16) was involved in the development of coronary heart disease (CHD). However, the mechanism of CD16 in contribution to CHD development remains largely unclear. Here, we focused on the signaling pathway it stimulates in the initiation and progression of CHD. Methods: We investigated FcγRIIIA mRNA expression in the leukocytes, serum protein level of soluble CD16 (sCD16) and membrane CD16 on monocytes in 100 diagnosed CHD patients and 40 healthy people at similar ages. We determined soluble CD14 (sCD14) to analyse whether monocytes are activated or not. Macrophage colony stimulating factor (M-CSF), TNFα and IL-1 in sera were determined as well. Furthermore, the role of FcγRIIIA in the initiation and progression of CHD was analysed by monocytes adherence to human umbilical vein endothelial cells (HUVECs) in vitro and aortic atherosclerotic formation in ApoE-/-mouse model in vivo. Results: There was a significant increase of Fcγ RIIIA at the mRNA level in leukocytes (1.372±0.454), the protein level of both serum sCD16 (3.237±0.988) and membrane CD16 on monocytes (4.8±2.2%) in CHD patients when compared to the healthy control. High level of sCD14 in sera (3.744±0.896 μg/ml) was found in CHD patients. Similar to sCD14, the levels of M-CSF (120.144±32.123 pg/ml), TNFα (48.297±11.545 pg/ml) and IL-1 (75.842±20.682 pg/ml) in sera were also higher in CHD patients. Further experiments showed that the elevated level of FcγRIIIA on monocytes dramatically correlated with the adhesive efficiency of HUVECs (10.5±5.5%) in vitro, and also aortic atherosclerotic formation in ApoE-/- mouse model, along with increased levels of TNFα (41.758±9.776 pg/ml), IL-1 (71.752±13.201 pg/ml;) and soluble E-selectin (sE-selectin) (2.977±0.560 μg/ml) in sera and both the mRNA level (3.968±0.284) and the protein level (0.455±0.018) of MMP-9 in aorta. Additionally, similar to Simvastatin, IVIG pretreatment inhibited this response in ApoE-/- mice. Conclusion: Taken together, these results demonstrate that FcγRIIIA plays a crucial role in the development of athersoclerotic formation by targeting inflammatory cytokines and MMPs, and inhibition of FcγRIIIA or its signaling may represent a promising approach for the prevention and treatment of CHD.